154 related articles for article (PubMed ID: 10083271)
1. Synergy of class I and class II MHC deficiency (C1D and C2D) islets and early short-term suppression in achieving long-term islet graft survival and tolerance induction.
Pittman K; Berzina P; Contreras J; Bilbao G; Thomas F; Thomas J
Transplant Proc; 1999; 31(1-2):635-6. PubMed ID: 10083271
[No Abstract] [Full Text] [Related]
2. Enhancement of islet allograft survival in mice treated with MHC class I specific F(ab')2 alloantibody.
Osorio RW; Ascher NL; Melzer JS; Stock PG
Transplant Proc; 1994 Apr; 26(2):749. PubMed ID: 8171642
[No Abstract] [Full Text] [Related]
3. Role of donor MHC class III genes in the destruction of transplanted islets in NOD mice.
Jevnikar AM; Prange S; Zucker P; Singh B
Ann N Y Acad Sci; 2002 Apr; 958():175-8. PubMed ID: 12021101
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of purified islet cells in diabetic rats. II. Immunogenicity of allografted islet beta-cells.
Pipeleers DG; Pipeleers-Marichal M; Vanbrabandt B; Duys S
Diabetes; 1991 Jul; 40(7):920-30. PubMed ID: 2060728
[TBL] [Abstract][Full Text] [Related]
6. Six- to eight-month survival of discordant pig islet xenografts documented by differential species, insulin, and C-peptide in animals given short-term immunosuppression.
Henretta J; McFadden T; Pittman K; Thomas J; Thomas F
Transplant Proc; 1994 Jun; 26(3):1138-9. PubMed ID: 8029861
[No Abstract] [Full Text] [Related]
7. Class I major histocompatibility complex antigen disparity is not a barrier to successful pancreatic islet cell engraftment.
Jain K; Cai BR; Patel S; Anderson M; Miller D; Smith BH; Rubin AL; Suthanthiran M
Transplant Proc; 1994 Dec; 26(6):3323-4. PubMed ID: 7998155
[No Abstract] [Full Text] [Related]
8. Islet endocrine cell MHC antigen expression in allograft rejection.
Markmann JF; Barker CF; Lo D; Brinster R; Tomaszewski J; Naji A
Transplant Proc; 1990 Apr; 22(2):847-8. PubMed ID: 2109416
[No Abstract] [Full Text] [Related]
9. Rat pancreatic islet pretreatment with anti-MHC class II monoclonal antibodies and culture: in vitro MLIC test response does not predict islet allograft survival.
Bretzel RG; Flesch BK; Brennenstuhl G; Greiner I; Hering BJ; Woehrle M; Federlin K
Acta Diabetol; 1993; 30(1):49-56. PubMed ID: 8329731
[TBL] [Abstract][Full Text] [Related]
10. A composite graft of islet plus donor lymph node cells induced donor specific tolerance in a "low responder" rat combination with class I MHC disparity.
Maeda A; Ito T; Yumiba T; Ohkawa A; Uchikoshi F; Tori M; Sawai T; Nozawa M; Matsuda H
Transplant Proc; 1999; 31(1-2):749-50. PubMed ID: 10083320
[No Abstract] [Full Text] [Related]
11. Long-term islet allograft function in the absence of chronic immunosuppression: a case report of a nonhuman primate previously made tolerant to a renal allograft from the same donor.
Kawai T; Sogawa H; Koulmanda M; Smith RN; O'Neil JJ; Wee SL; Boskovic S; Sykes M; Colvin RB; Sachs DH; Auchincloss H; Cosimi AB; C Ko DS
Transplantation; 2001 Jul; 72(2):351-4. PubMed ID: 11477369
[TBL] [Abstract][Full Text] [Related]
12. The effect of reduction of class II antigens on the survival of pancreatic allografts.
Spillenaar-Bilgen EJ; Bouwman E; de Bruin RW; Marquet RL; Jeekel J
Transplant Proc; 1989 Feb; 21(1 Pt 1):515-6. PubMed ID: 2495619
[No Abstract] [Full Text] [Related]
13. Role of intra-islet endothelial cells in islet allo-immunity.
Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
[TBL] [Abstract][Full Text] [Related]
14. Studies of privileged sites and islet transplantation.
Barker CF; Markmann JF; Posselt AM; Naji A
Transplant Proc; 1991 Aug; 23(4):2138-42. PubMed ID: 1871831
[No Abstract] [Full Text] [Related]
15. In vitro function and xenotransplantation of long-term (3 weeks) cultured porcine islets of Langerhans.
Marchetti P; Swanson C; McLear M; Finke E; Gerasimidi-Vazeou A; Scharp DW; Lacy PE
Transplant Proc; 1992 Apr; 24(2):637. PubMed ID: 1566461
[No Abstract] [Full Text] [Related]
16. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
Beilke J; Johnson Z; Kuhl N; Gill RG
Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
[TBL] [Abstract][Full Text] [Related]
17. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of acquired thymic tolerance to rat islet allografts by regulatory/suppressor T cells.
Saborio DV; Chowdhury NC; Hardy MA; Oluwole SF
Transplant Proc; 1999; 31(1-2):897. PubMed ID: 10083395
[No Abstract] [Full Text] [Related]
19. Pretreatment of rat pancreatic islets with MHC I-A monoclonal antibody: in-vitro and in-vivo effects on islet antigenicity.
Flesch BK; Bretzel RG; Otto DA; Ernst-Schlegel M; Federlin K
Horm Metab Res; 1991 Aug; 23(8):357-61. PubMed ID: 1794836
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of rat islet allografts with the use of ultraviolet irradiation, without immunosuppression.
Hardy MA; Lau H; Reemtsma K
Transplant Proc; 1984 Jun; 16(3):865-9. PubMed ID: 6233774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
